| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 12/14/2005 | CN1231583C Method for generating split, non-transferable genes that are able to express an active protein product |
| 12/13/2005 | CA2234073C Coiled-coil heterodimer methods and compositions for the detection and purification of expressed proteins |
| 12/08/2005 | WO2005116082A1 2-cysteine peroxiredoxin complex exhibiting function acting as molecular chaperone and uses thereof |
| 12/08/2005 | WO2005116078A1 Glycosylated immunoglobulin and immunoadhesin comprising the same |
| 12/08/2005 | US20050272658 Applications of peptides derived from the cytoplasmic domain of amyloid precursor protein (APP) |
| 12/08/2005 | US20050272128 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity |
| 12/08/2005 | US20050271655 Nogo receptor antagonists |
| 12/08/2005 | US20050271620 Herpes simplex virus complex |
| 12/08/2005 | CA2574096A1 Glycosylated immunoglobulin and immunoadhesin comprising the same |
| 12/08/2005 | CA2563999A1 Keratin-binding polypeptides |
| 12/07/2005 | EP1601698A1 Physiologically active polypeptide conjugate having prolonged in vivo half-life |
| 12/07/2005 | EP1601684A2 Compositions and methods employing alternative reading frame polypeptides for the treatment of cancer and infectious disease |
| 12/07/2005 | EP1601332A2 Hydrolases, nucleic acids encoding them and mehods for making and using them |
| 12/07/2005 | CN1230542C Production of proteins by autoproteolytic cleavage |
| 12/07/2005 | CN1230536C Tie-2 ligands, methods of making and uses thereof |
| 12/06/2005 | US6972322 Polypeptide for use in the treatment of cancerous, angiogenesis, inflammatory shock and autoimmune diseases |
| 12/06/2005 | US6972318 Complex of a chaperone protein with amyloid |
| 12/01/2005 | WO2005114220A2 Compositions, kits, and methods for calibration in mass spectrometry |
| 12/01/2005 | WO2005113792A1 Probe for detection/determination of inositol-1,4,5-triphosphoric acid and method of detecting/determining inositol-1,4,5-triphosphoric acid with the same |
| 12/01/2005 | WO2005113583A1 An expression system comprising operably linked rgg gene and gtfg promoter |
| 12/01/2005 | WO2005087808A3 Growth factor binding constructs materials and methods |
| 12/01/2005 | WO2005065015A3 Neutralizing antibodies and methods of use thereof |
| 12/01/2005 | US20050268350 Identification and purification of higher order transcription complexes from transgenic non-human animals |
| 12/01/2005 | US20050267293 Loading solution onto a hydrophobic interaction chromatography matrix equilibrated in aqueous buffer at a salt concentration high enough to promote matrix-protein interactions, applying a gradient of decreasing salt concentration, and collecting the conjugate, leaving the unconjugated albumin |
| 12/01/2005 | US20050267024 Polypeptide, cancer therapy, neovascularization defects, retinopathies, arthritis and psoraisis |
| 12/01/2005 | US20050266533 Therapeutic fusion protein with enhanced for use in prevention and treatment of cell proliferative, blood and nervous system disorders |
| 12/01/2005 | US20050266532 Albumin fusion proteins |
| 12/01/2005 | US20050266486 Methods for treating obesity by inhibiting expression of obese gene product receptor variant |
| 12/01/2005 | US20050266002 Methods for the treatment of cancer using anti-CD40 antibodies |
| 12/01/2005 | US20050265965 Modified cytokines for use in cancer therapy |
| 12/01/2005 | CA2567650A1 A probe for detection and quantification of inositol-1,4,5-trisphosphateand a method for detecting and quantifying inositol-1,4,5-trisphosphate using the same |
| 12/01/2005 | CA2567501A1 An expression system comprising operably linked rgg gene and gtfg promoter |
| 11/30/2005 | EP1599572A2 Compositions and methods for cancer immunotherapy |
| 11/30/2005 | EP1599504A1 Modified antibody |
| 11/30/2005 | EP1437937A4 Method for formulating and immobilizing a protein matrix and a protein matrix for use in a sensor |
| 11/30/2005 | EP1430131B1 Muteins of human neutrophil gelatinase-associated lipocalin and related proteins |
| 11/30/2005 | EP1301605B1 Nk cells activating receptors and their therapeutic and diagnostic uses |
| 11/30/2005 | CN1703423A Antagonists il-15 |
| 11/29/2005 | CA2146964C Particles having gelatin-aminodextran coatings of and processes for making same |
| 11/24/2005 | WO2005111071A1 Complex containing protein with ligand binding capacity, and method of screening substance capable of binding to protein with ligand binding capacity |
| 11/24/2005 | WO2005058958A3 Novel glp-1 analogues linked to albumin-like agents |
| 11/24/2005 | US20050261478 For activating T and/or B cells by aggregating three or more cell surface antigens; the activation signals may result in either immune enhancement or immunosuppression |
| 11/24/2005 | US20050261229 Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens |
| 11/24/2005 | US20050260616 Nucleotide and protein sequences of Nogo genes and methods based thereon |
| 11/24/2005 | US20050260598 Novel clot-specific streptokinase proteins possessing altered plasminogen activation characteristics and a process for the preparation of said protein |
| 11/24/2005 | US20050260587 Synthetic transfer complex and method for transferring nucleic acids |
| 11/24/2005 | US20050260220 first component is the modified antigenic ectodomain of measles virus hemagglutinin protein, second component fused to first component that binds a surface protein of human immunodeficiency virus; for treating HIV infection and other therapeutic targets against which it is difficult to develop vaccines |
| 11/24/2005 | US20050260216 Polypeptide containing a mutation characteristic of an analogous non-human protein; is capable of raising antibodies in human, antibodies bind to both the human protein and the polypeptide |
| 11/24/2005 | US20050260215 Conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate |
| 11/24/2005 | US20050260207 Monoclonal antibody neutralising cathepsin b activity and uses thereof |
| 11/24/2005 | US20050260154 G-CSF analog compositions and methods |
| 11/23/2005 | EP1598370A2 Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions |
| 11/23/2005 | EP1597585A2 Method for selecting a candidate drug compound |
| 11/23/2005 | EP1597273A2 Soluble ctla4 polypeptides and methods for making the same |
| 11/23/2005 | EP1596806A2 Compositions and methods for treating cancer using igsf9 and liv-1 |
| 11/23/2005 | EP1596804A2 SOLUBLE FcyR FUSION PROTEINS AND METHODS OF USE THEREOF |
| 11/23/2005 | EP1381628B1 Inflammation-specific peptides and the uses thereof |
| 11/23/2005 | EP1078007B1 Verotoxin b subunit for immunization |
| 11/23/2005 | EP1039930B1 ADJUVANTED VACCINE COMPRISING AN ANTIGEN FROM STREPTOCOCCUS PNEUMONIAE AND A CpG OLIGONUCLEOTIDE |
| 11/23/2005 | CN1700930A Methods and reagents relating to inflammation and apoptosis |
| 11/23/2005 | CN1699425A Method for preliminary purification of recombinant human parathormone fusion protein by thermo osmosis shock technology |
| 11/23/2005 | CN1699424A Heparinase I fusion protein and genes encoding same and expression method thereof |
| 11/23/2005 | CN1228446C Conotoxin MVII A and Trx fusion protein and its expression and application |
| 11/22/2005 | US6967092 Multi-functional chimeric hematopoietic receptor agonists |
| 11/17/2005 | WO2005107790A1 Hybrid recombinases for genome manipulation |
| 11/17/2005 | WO2005107785A2 Human complement c3 derivates with cobra venom factor-like function |
| 11/17/2005 | WO2001072768A8 Single chain class i major histo-compatibility complexes, constructs encoding same and methods of generating same |
| 11/17/2005 | WO1997049725A9 Modified factor viii |
| 11/17/2005 | US20050256053 Combined use of a GLP-1 compound and another drug for treating dyslipidemia |
| 11/17/2005 | US20050256049 Chimeric toxins for targeted therapy |
| 11/17/2005 | US20050255550 Suppression of xenotransplant rejection |
| 11/17/2005 | US20050255115 T-cell surface glycoprotein specific immunoglobulin for use in treatment and prevention of cell proliferative disorders; immunotherapy |
| 11/17/2005 | US20050255099 Antigenic fusion protein carrying Galalpha 1,3Gal epitopes |
| 11/17/2005 | CA2565227A1 Human complement c3 derivates with cobra venom factor-like function |
| 11/17/2005 | CA2563521A1 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 11/17/2005 | CA2562552A1 Hybrid recombinases for genome manipulation |
| 11/16/2005 | EP1594443A2 Immunogenic cd19 ligand-antigenic molecule complexes and fusion proteins |
| 11/16/2005 | CN1227360C Tumor-associated antigen derivatives from MAGE family, and nucleic acid sequence encoding them |
| 11/16/2005 | CN1227265C Antibodies to CCR5 |
| 11/15/2005 | US6965024 Reactive with ganglioside GD3; cancer treatment |
| 11/15/2005 | US6965018 Antibodies directed to B7-related polypeptide, BSL-2 |
| 11/15/2005 | US6965011 Identification and characterization of extracellular polypeptides having homology to EGF |
| 11/15/2005 | US6965010 Polypeptideeptide for use in the treatment of cancer, neovascularization defects, retinopathies, arthritis and psoraisis |
| 11/15/2005 | US6964767 Polypeptides; detecting infections using antibodies |
| 11/15/2005 | CA2182315C Expression of heterologous proteins in attenuated bacteria using the htra-promoters |
| 11/10/2005 | WO2005105850A1 Double brilliance beta-arrestin: a biosensor for monitoring the activity of receptors and signalling molecules, and method of using same |
| 11/10/2005 | US20050250936 Modified TGF-beta superfamily proteins |
| 11/10/2005 | US20050250934 synthetic peptide conjugate compositions for the treatment of immunoglobulins (IgE)-mediated allergic diseases by active immunization |
| 11/10/2005 | US20050250933 Vaccines |
| 11/10/2005 | US20050249746 useful in inducing a protective immune response against NTHi in an immunized human |
| 11/10/2005 | US20050249738 Immunotoxins directed against malignant cells |
| 11/10/2005 | US20050249728 Anti-IGF-I receptor antibody |
| 11/10/2005 | US20050249701 Il-7 Drug substance, composition, preparation and uses |
| 11/10/2005 | CA2607015A1 Double brilliance beta-arrestin: a biosensor for monitoring the activity of receptors and signalling molecules, and method of using same |
| 11/09/2005 | EP1285065B1 Long wavelength engineered fluorescent proteins |
| 11/09/2005 | EP0939769B1 Vertebrate smoothened proteins |
| 11/09/2005 | EP0750457B1 Targeted cytolysis of hiv-infected cells by chimeric cd4 receptor-bearing cells |
| 11/09/2005 | EP0719330B1 Protocadherin proteins and their uses |
| 11/09/2005 | CN1694961A Collectin-complement activating protein chimeras |
| 11/09/2005 | CN1694722A A process for the preparation of a non-toxic anthrax vaccine |